Archives: Speakers

Jen Manzi is a Subject Matter Expert and User Advocate at Pinnacle 21. She has over 20 years of Pharma/Life Sciences industry experience in Clinical Trials and Safety Data Management. Jen has held various roles within these areas, including eCRF Programmer, SDTM Delivery Lead, Product Owner and Programmer of Batch Processes, Vendor Relationship Manager, Program and Process Improvement Manager, and Validation Lead.

Christie is a senior clinical leader at Revvity Signals, bringing over 20 years of experience across life sciences and clinical analytics. She has deep expertise spanning clinical trials, real-world evidence, vaccine development, and genomics, with a career focused on translating complex clinical data into actionable insight. Throughout her work, Christie has helped shape and guide enterprise clinical solutions used across biotechnology and healthcare organizations worldwide.

Robin Emmanuel is a Sourcing & Contract Manager at Coloplast, where he leads strategic sourcing, contracting, and vendor governance activities supporting global clinical development programs. He brings extensive experience in sponsor-CRO partnerships, clinical trial outsourcing, and contract strategy, with a strong focus on building collaborative operating models that enable efficient, compliant, and high-quality clinical trial execution.

Thomas Otto is a Senior Management Consultant and Head of CIO Advisory at Sopra Steria Next Germany. He advises financial institutions, automotive finance organizations, and public sector clients on digital transformation, AI strategy, IT governance, cloud transformation, and operating model design. With extensive experience in highly regulated environments, Thomas supports executives in translating emerging technologies into sustainable business value while aligning governance, compliance, and organizational change. He has led numerous large-scale transformation and AI initiatives, helping organizations move from experimentation to enterprise-wide adoption. His focus is on building trusted AI capabilities that enable innovation, scalability, regulatory compliance, and measurable business outcomes.

Carsten Rudolph, PhD is a co-founder and CEO of Ethris and the lead inventor of its SNIM® RNA Technology. His deep expertise is delivering mRNA specifically to the lungs. He is the inventor of 15 patents/applications and has authored more than 120 scientific publications. Carsten is affiliated with the Dr. von Haunersche Children’s Hospital, part of Ludwig Maximilian University in Munich. He obtained his pharmaceutical degree from the Freie Universität Berlin.

Izumi Sugimoto is Director of the Alliance Management Department at EPS Corporation. Since joining EPS in 2004, she has gained approximately 20 years of experience in clinical development services, including pharmaceutical and medical device clinical trials as a CRA. She has also managed specialized clinical trial operations, including operational support for Independent Data Monitoring Committees, central imaging review support, and vendor oversight. More recently, she has been engaged in business strategy and alliance-related initiatives, focusing on collaboration models with partner CROs and other external clinical development partners that support global biotech sponsors.

Mayumi Yamamoto is Executive Officer and Head of the Data Science Center at EPS Corporation, overseeing clinical data management and biostatistics. Since joining EPS in 2005, she has built approximately 18 years of experience in clinical data management, including serving as a Data Management Lead for multinational clinical trials across Asia. She subsequently expanded her role into new business development, including the planning of new business initiatives involving Real-World Data (RWD) and leading the company’s decentralized clinical trial (DCT) task force. More recently, she has been leading strategic collaborations in the data science area with U.S. local CROs and global CROs, with a focus on enabling smoother and more effective execution of multi-regional clinical trials (MRCTs).

Askold Kozbur is an experienced Director of Business Development located in the Chicago, USA area.  Mr. Kozbur has over 40 years of sales and marketing experience with medical products and services. The most recent 25 years of his experience is in the Clinical Trial Industry in which he held and holds business development and account management positions at various CROs.  Mr. Kozbur has been with EPS since 2011.

Askold Kozbur earned a Master of Science in Administration from the Graduate School of Administration (currently Paul Merage School of Business) at the University of California, Irvine.  Mr. Kozbur also holds a Bachelor of Science from the School of Biological Sciences at the University of California, Irvine (graduated Cum Laude).

With over 25 years of global experience, Vish is a self-motivated and versatile professional possessing unique blend of technical and business expertise with a broad perspective that comes from having worked in diverse industries.